Scientific Advice (SA) is one of the important interactions a developer can have with a regulatory agency (national or European level). It can facilitate the development and availability of high-quality, effective and acceptably safe medicines, for the benefit of patients. In this session, we answer the questions on SA such as:
- When the developer can request a SA?
- What are the different SA procedures?
- Why request a SA?
- What’s the difference between a National Scientific Advice vs an EMA scientific Advice?